๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione

โœ Scribed by Robert C. Stein; Mitchell Dowsett; Anthea Hedley; Joanna Davenport; Jean-Claude Gazet; Hubert T. Ford; R. Charles Coombes

Publisher
Springer
Year
1990
Tongue
English
Weight
372 KB
Volume
26
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The treatment of postmenopausal women wi
The treatment of postmenopausal women with advanced breast cancer with buserelin
โœ J. H. Waxman; S. J. Harland; R. C. Coombes; P. F. M. Wrigley; J. S. Malpas; T. P ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 239 KB

Repeated administration of long-acting analogues of gonadotrophin-releasing hormone down-regulates the pituitary gonadotrophins and gonadal hormones. The activity of these compounds in premenopausal women with breast cancer has been previously noted. In an attempt to cause a highly selective medical

Use of aromatase inhibitors in postmenop
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer
โœ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 39 KB ๐Ÿ‘ 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast